Glaxo Is STILL testing Paxil on 7-year-olds despite proven suicide risks

This story just shows little Glaxo cares and what a thick skin the drugs giant has. It’s from BNET UK by Jim Edwards.

Bob Fiddaman over at Seroxat Sufferers has also picked up on this and gone straight for the jugular (in his usual fashion!) writing to Glaxo demanding a full explanation: “As a matter of public record I would like either GlaxoSmithKline UK or GlaxoSmithKline Japan to explain why this study has been put in place. In other words, what is GlaxoSmithKline’s motive behind this study?”

Bob and I have been doing this for all too long and I don’t think either of us will be holding our breath waiting for any sort of reply from Glaxo.

Here’s the Jim Edwards piece:

It was established years ago that Paxil carries a risk of suicide in children and teens, but GlaxoSmithKline (GSK) has for the last 18 months been conducting a study of the antidepressant in kids as young as seven — in Japan. It’s not clear why the company would want to draw more attention to its already controversial pill, but it appears as if GSK might be hoping to see a reduced suicide risk in a small population of users — a result the company could use to cast doubt on the Paxil-equals-teen-suicide meme that dominates discussion of the drug.

GSK didn’t immediately respond to a request for comment. A staffer on GSK’s trials hotline confirmed the study was ongoing, however. The drug carries a “black box” warning on its patient information sheet, warning doctors and consumers that the antidepressant is twice as likely to generate lethal thoughts than a placebo.

The trial criteria listed on, however, provide an interesting lesson in how managers can carefully design drug trials designed to flatter their products — something good companies don’t do.

The primary aim of the study is not to find out why Paxil makes some children kill themselves. Rather, it’s yet another efficacy study, which the drug doesn’t need because it was approved years ago — we already know the drug works.

Paxil is being tested against a placebo, so the results won’t be very surprising — even terrible drugs work better than sugar pills. [Or maybe not in the case of Paxil – see this story].

To what degree Paxil triggers suicide is only a secondary aim of the study. If the results suggest a lower suicide risk, expect GSK to play them up. If they’re bad, expect the company to dismiss them in favor of the primary endpoint results.

About 130 children have been enrolled, according to, which puts about 65 patients in each arm. That means the results won’t be too statistically robust — there only need to be two or three outlier results to skew the numbers by several percentage points.

The trial will wrap up in September.



One Response to “Glaxo Is STILL testing Paxil on 7-year-olds despite proven suicide risks”

  1. truthman30 Says:

    This is very very disturbing.. I am rarely lost for words when it comes to seroxat and GSK , but really this news has me slightly bewildered i have to admit.. I haven’t been blogging much lately because of other commitments but I have some time off now for a while and I intend to get back to my blog very soon, and I will be investigating this story further..but for now i would just like to say, it seems insane to me that gsk would be testing paxil on children again, it’s quite shocking really. It would be similar to testing thalidomide again on pregnant women just to see what kind of birth defects happen as a result.. Utterly bizarre and truly shocking stuff..

Leave a Reply

Fill in your details below or click an icon to log in: Logo

You are commenting using your account. Log Out / Change )

Twitter picture

You are commenting using your Twitter account. Log Out / Change )

Facebook photo

You are commenting using your Facebook account. Log Out / Change )

Google+ photo

You are commenting using your Google+ account. Log Out / Change )

Connecting to %s

%d bloggers like this: